The Medical Genetics market is a subset of the Genomics market, focusing on the application of genetic information to medical diagnosis, treatment, and prevention. It involves the use of genetic testing to identify genetic disorders, as well as the use of genetic information to inform medical decisions. This market is driven by advances in technology, such as next-generation sequencing, which has enabled the rapid and cost-effective sequencing of entire genomes. The Medical Genetics market is composed of a variety of stakeholders, including healthcare providers, diagnostic laboratories, pharmaceutical companies, and research institutions. These stakeholders are involved in the development and delivery of genetic tests, as well as the interpretation and application of genetic information. Some companies in the Medical Genetics market include Illumina, Thermo Fisher Scientific, BGI, and 23andMe. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
